Greater Glasgow and Clyde Medicines

Forthcoming discontinuation of Priadel Tablets

Priadel discontinuation- update

Key points

  • The Competition and Market Authority (CMA) has launched an investigation into the planned withdrawal of Priadel tablets by Essential Pharma
  • Whilst this investigation is ongoing any switch to an alternative lithium preparation is being put on hold
  • In the meantime, patients should continue to be prescribed their current brand of lithium carbonate
  • Patients who are to be initiated on lithium carbonate tablets should be prescribed Priadel as set out in the Good Practice Standards- Safe Lithium Treatment


Published 15/10/2020

Medicines Update blogs are correct at the time of publication